FSHR and ovarian carcinoma: To specifically deliver genetic drugs including siRNA into ovarian cancer tissues, we recently developed a novel gene delivery system, polyethylene glycol (PEG)-polyethylenimine (PEI) complex modified with FSH β 33–53 peptide, to deliver siRNA carried by NPs into FSHR-positive cells [10].